Colombia introduced mass pneumococcal conjugate vaccination at the end of 2011. Using 2005–2015 surveillance data, we conducted a retrospective interrupted time-series analysis. A significant trend towards reduced monthly was observed in the post-vaccination period (2012–2015) compared with the expected rate, reaching in 2015 a reduction of 90.5% of pneumococcal meningitis. This trend was not observed for control diseases.
CITATION STYLE
Caceres, D. C., Ortega-Barria, E., Nieto, J., & DeAntonio, R. (2018). Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis. Human Vaccines and Immunotherapeutics, 14(5), 1230–1233. https://doi.org/10.1080/21645515.2018.1425115
Mendeley helps you to discover research relevant for your work.